Tendel Therapies Inc.

Funding and NIH signals

• NIH award NIH awarded $1M (SBIR Phase II 5R44AI192249-02, continuation, notice Aug 4, 2026). NIH RePORTER 5R44AI192249-02 (Aug 4, 2026)
  Evidence (1 event)

  • Aug 4, 2026 · NIH RePORTER 5R44AI192249-02
    Organization: TENDEL THERAPIES INC.; City/State: KENSINGTON, CA; Project number: 5R44AI192249-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-04; FY total cost (award amount): 999990; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Optimizing SIV reservoir depletion by Tendel bsAb-98; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals